Cost-effectiveness of clopidogrel, prasugrel and ticagrelor for dual antiplatelet therapy after acute coronary syndrome: a decision-analytic model

BACKGROUND: The use of prasugrel or ticagrelor as part of dual antiplatelet therapy with acetylsalicylic acid after acute coronary syndrome (ACS) improves clinical outcomes relative to clopidogrel. The relative cost-effectiveness of these agents are unknown. We conducted an economic analysis evaluat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CMAJ Open
Hauptverfasser: Abdel-Qadir, Husam, Roifman, Idan, Wijeysundera, Harindra C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 8872147 Canada Inc. 2015
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4701656/
https://ncbi.nlm.nih.gov/pubmed/26770967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20150056
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge